Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
258.32
+11.38 (4.61%)
At close: Mar 31, 2026, 4:00 PM EDT
257.00
-1.32 (-0.51%)
After-hours: Mar 31, 2026, 6:14 PM EDT
Krystal Biotech Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$297.60
Upside
+15.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Mar 27, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $224 → $284 | Strong Buy | Maintains | $224 → $284 | +9.94% | Feb 25, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $336 → $371 | Strong Buy | Maintains | $336 → $371 | +43.62% | Feb 18, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $220 → $323 | Strong Buy | Maintains | $220 → $323 | +25.04% | Feb 18, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $310 → $371 | Strong Buy | Maintains | $310 → $371 | +43.62% | Feb 17, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $206 → $327 | Strong Buy | Maintains | $206 → $327 | +26.59% | Feb 2, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $288 → $318 | Strong Buy | Maintains | $288 → $318 | +23.10% | Jan 22, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $320 → $336 | Strong Buy | Maintains | $320 → $336 | +30.07% | Jan 12, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $202 → $306 | Strong Buy | Maintains | $202 → $306 | +18.46% | Jan 9, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $309 → $320 | Strong Buy | Maintains | $309 → $320 | +23.88% | Jan 9, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $240 → $310 | Strong Buy | Reiterates | $240 → $310 | +20.01% | Jan 9, 2026 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $198 → $309 | Hold → Strong Buy | Upgrades | $198 → $309 | +19.62% | Jan 6, 2026 |
| Citigroup | Citigroup | Hold Maintains $166 → $198 | Hold | Maintains | $166 → $198 | -23.35% | Nov 4, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $216 → $220 | Strong Buy | Maintains | $216 → $220 | -14.83% | Nov 4, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $182 → $255 | Strong Buy | Maintains | $182 → $255 | -1.29% | Oct 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $240 | Strong Buy | Reiterates | $240 | -7.09% | Sep 15, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.